Skip to main content
. 2020 May 29;9(6):1640. doi: 10.3390/jcm9061640

Table 1.

Patient characteristics at the beginning of the study.

STEMI Group (n = 66) NSTEMI Group (n = 44) Control Group (n = 100) p-Value Control Group vs. MI Group p-Value STEMI vs. NSTEMI Group
Age (y) 62.4 ± 9.7 64.2 ± 10.1 61.5 ± 7.9 NS NS
Sex women 6 p. (9.1%) 16 p. (36.4%) 34 p. (33.7%) NS p < 0.005
men 60 p. (90.9%) 28 p. (63.6%) 67 p. (66.3%) NS p < 0.005
BMI (kg/m2) 27.1 ± 2.4 27.5 ± 3.5 26.9 ± 3.4 NS NS
Smoking (n) 40 p. (60.6%) 26 p. (59.1%) 28 p. (28%) p < 0.001 NS
Hypertension (n) 44 p. (66.7%) 27 p. (61.4%) 0 p. - NS
Diabetes t.2 (n) 12 p. (18.2%) 5 p. (11.4%) 0 p. - NS
Hyperlipidemia (n) 25 p. (37.9%) 19 p. (43.2%) 0 p. - NS
Systolic BP (mmHg) 144.1 ± 24.0 146.2 ± 25.0 132.8 ± 19.0 p < 0.05 NS
Diastolic BP (mmHg) 88.6 ± 15.6 88.8 ± 13.6 83.0 ± 8.0 NS NS
Total cholesterol (mmol/L) 4.96 ± 1.0 4.91 ± 0.95 4.40 ± 0.9 p < 0.05 NS
LDL cholesterol (mmol/L) 3.19 ± 0.95 3.11 ± 0.89 2.74 ± 0.8 p < 0.05 NS
HDL cholesterol (mmol/L) 1.15 ± 0.3 1.2 ± 0.24 1.6 ± 0.35 p < 0.05 NS
TG (mmol/L) 1.59 ± 0.95 1.53 ± 0.87 1.42 ± 0.54 NS NS
Glucose (mmol/L) 6.35 ± 1.4 5.8 ± 1.3 5.65 ± 1.1 p < 0.05 p < 0.05
Creatinine (µmol/L) 91.05 ± 28.0 79.6 ± 19.5 89.2 ± 14.8 NS p < 0.05
GFR (mL/min) 82.7 ± 25.6 87.1 ± 23.7 109.5 ± 30.0 p < 0.01 NS
Haemoglobin (mmol/L) 8.7 ± 0.8 8.5 ± 0.7 8.9 ± 1.0 NS NS
EF (%) 45.9 ± 9.5 49.7 ± 10.1 55.0 ± 12.5 p < 0.01 NS (p = 0.05)
1-vessel disease (n) 25 p. (37.9%) 15 p. (34.1%) - - NS
2-vessel disease (n) 15 p. (22.7%) 7 p. (15.9%) - - NS
3-vessel disease (n) 25 p. (37.9%) 17 p. (38.6%) - - NS

BMI—body mass index, BP—blood pressure, EF—ejection fraction, GFR—glomerular filtration rate, HDL—high density lipoprotein, LDL—low density lipoprotein, MI—myocardial infarction, NS—not statistically significant, NSTEMI—non-ST-elevation myocardial infarction, p.—patients, STEMI—ST-elevation myocardial infarction, TG—triglycerides.